chrisvoncsefalvay/vaers-outcomes huggingface dataset:
nausea; tiredness; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th April 2019, the patient received Shingrix. On 19th April 2019, less than a day after receiving Shingrix, the patient experienced tiredness. On 22nd April 2019, the patient experienced nausea. On 21st April 2019, the outcome of the tiredness was recovered/resolved. On an unknown date, the outcome of the nausea was recovering/resolving.   It was unknown if the reporter considered the tiredness and nausea to be related to Shingrix.  Additional details were provided as follows: The patient experienced extreme tiredness which continued until the date of reporting. On the date of reporting, 3 days after receiving the Shingrix, she was experiencing nausea. Consented to follow up.
Intern admnistered boostrix in one arm and menactra in the other. He stated patient was a little nervous and after giving the second vaccine the patient started to feint. Intern layed patient on the groud and called me. When I arrived patient was concious but was hyperventilating and still feeling dizzy. Raised the patient's feet and tried to get her to breath slower and called mergency services. With the help of the nurse next door we got her BP (98/56), pulse (98), temperature (99.4). Patient also started to feel cold so we got her a blanket. Eventually patient was able to sit on the chair with a bit of help. When emergency services arrived at the scene they took vitals again and patient's caregivers declined a ride to the hospital. Patient and family left shortly after emergncy services.
Inflammation and swelling of the lymph nodes on the left and right side. Still experiencing sharp pain on the left side
suspected vaccination failure/ took the shot and got them; got them four times; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient took the shingle shot and got shingles four times. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Pt given shot HPV into left arm. After about 1-2 min her eyes rolled back in her head and she appeared to have fainted. Came to within appx 30-45 sec. Was coherent afterwards but felt weak and dizzy. Pt was assisted to lie down. Bp checked 96/50. Given fluids/snack. Stayed in office for appx an hr afterwards. Ambulated out.
Friday 9/3. Symptoms the day after vaccine were normal - left arm very sore to the point where I couldn't lift it and very fatigued. Felt as though a cloud covered my eyes and head.  Saturday 9/4. Arm still very sore, no better than the day before. Still feeling fatigued but not as bad as the day prior.  Sunday 9/5. Arm starting to get better but woke up with a tickle in my throat. Still a bit fatigued but better. Monday 9/6. Arm is back to normal. Not fatigued. Tickle in my throat is a bit worse. Allergy symptoms start coming on (sneezing, runny nose, congestion) ***Tuesday 9/7. Felt the same as Monday until about 8pm. My legs went numb and and whole body started shaking uncontrollably. This didn't let up for the entire night. I was sweating profusely, with shooting pains up and down my body. Puked violently twice. Couldn't sleep all night and developed a headache that didn't let up until the next morning after taking Advil.  Wednesday 9/8. Developed a cough. Whole body aches and congestion. Headache and nausea. Thursday 9/9. Same symptoms as Wednesday.   Tuesday felt as though I was on my deathbed. I feel that is odd since it was 5 days after receiving the vaccine, and I'm still feeling very ill.
pt recvd vax & devel a papular rash 2 days p/vax;there were a few pustular lesions, more on the side of the inj site;no tx was given;few days p/vax pt seen by MD & hospitalized w/a blood sugar of 582;tx oral diabetic meds;
Headache, nausea w/o vomiting, myalgias, fatigue, small bruise on arm, paresthesias in her feet
Severe headache  on night of shot and  every day  since Tiredness  daily causing sleep  of up.to 20 hours  per day
Patient received first dose of COVID vaccine earlier this morning. A few minutes later, felt some throat tightness. No hives, wheezing, face swelling. On exam, no stridor, wheezing, rash; posterior OP clear. Doubt anaphylaxis, most c/f allergic reaction. Mother notes food allergies, no prior epi pen use. No hypoxia. Tolerating PO and secretions. Treated with dose of 25mg PO benadryl and will transfer to ED for continued observation. No stridor, facial swelling, posterior OP swelling throughout observation in clinic prior to transfer to EMS care. Deferred epinephrine.
Pt received both doses of the Moderna COVID-19 vaccines (on 4/20/2021 and 5/19/2021), and still tested positive for COVID-19 on 11/8/2021, subsequently requiring hospitalization and inpatient treatment.
Client stated she stated a day after the vaccination that she had an enlarged lymph node in her right arm pit.  It was swollen, painful, and very tender.  Stated on 9/13/2021 that the pain is much better and swelling is going down.  No treatment was needed.
Case number PHEH2015US020610, is an initial spontaneous report received from a nurse on 13 Oct 2015. This report refers to a 30 year old female patient. Medical history and concomitant medication were not reported. The patient was vaccinated with an expired dose of FLUVIRIN (batch number: 1412701) at a dose of 0.5 ml, intramuscularly on 08 Oct 2015. No adverse event was reported following this medication error.
Localized reaction mild. No fever. Erythema in area surrounding the initial PNEUMOVAX vaccine. No treatment.
A few minutes after injection slight headache, around 16 minutes or so- warmth/ache/almost numb pain from injection site side (shoulder, neck, jaw, behind ear, completely R sided). Very strange pain.   The headache resolved. The above pain persisted for 48 hours , with upper arm soreness (expected), and R neck pain /soreness for two days. The R jaw/ear pain (almost a numb/ache) mild after 3-4 days
It started with my eye swelling - like an eyelid and around the right side of my face. I had fatigue and really bad headache (that went away after a day). My right eye remained swollen. I took a pack of steroids for it - Methylprednisolone (I went back to the Pharmacy for it). I took that and today is my last day of it - I'm tapering off and the symptoms are returning and so I am probably going to need to go to the doctor again. It never completely went away....but it had improved.
Semi numb tongue, hive face, (swelling of face, hands, arms, feet, ankles, legs).
No adverse events beyond typical side effects.  Individual indicated nausea   Only reporting because patient was administered 1.0ml of the Moderna COVID 19 vaccine.  A double dose
pt recv vax 1OCT97 & INR of 15.6 reported 27OCT97 requiring ER visit & SC vit K;pt reported no bleeding;
This spontaneous report as received from a physician refers to a 15 year old patient of unknown gender. No information on the patient's concurrent conditions, medical history and concomitant medications was reported. On 07-AUG-2017, the patient was vaccinated with improperly stored GARDASIL 9 lot # N000326, expiry date 14-DEC-2019 (dose, route of administration were not provided). Data logger was not involved. No adverse event was reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA012770: US-009507513-1709USA012767: US-009507513-1709USA012768: US-009507513-1709USA012769: US-009507513-1709USA012765: US-009507513-1709USA007325: US-009507513-1709USA012766: US-009507513-1709USA012764.
This spontaneous report was received from a physician via a company representative and refers to a female patient of unknown age. The patient's medical history included hypothyroidism. No concurrent conditions or concomitant therapies were reported. In approximately May 2015 (reported as "about two months ago"), the patient was vaccinated with ZOSTAVAX (lot #, expiration date, dose, route and anatomical location were not reported). On approximately 13-JUL-2015 (reported as "about 2 weeks ago"), the patient visited the office where she presented with fever and weight loss. The patient also mentioned, that she had hyperthyroidism after receiving treatment with ZOSTAVAX, but it was unspecified if this was an official diagnosis from a physician or simply a statement offered by patient. The patient sought medical attention, she visited the office. The outcome of the events was unknown. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
after the first does had sores on my left back hip; This is a spontaneous report received from a contactable consumer (patient).   A 66-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL9261), via an unspecified route of administration in the left arm on 30Jan2021 (at the age of 66-year-old), as single dose for COVID-19 immunization at a Pharmacy. The patient was not pregnant at the time of vaccination. The patient's medical history included sarcoidosis. The patient had no known allergies. The patient did not have COVID prior vaccination. The patient was not tested post vaccination for COVID. Concomitant medications included Prednisone, Azathioprine, Gabapentine and Hydoxychor. On 11Feb2021, the patient reported that after the first does had sores on her left back hip. Adverse event required physician office visit. The patient did not receive any treatment for the event. The outcome of the event was not recovered.  No follow-up attempts are required. No further information is expected.
Swelling under his armpit; He said that he feels a little pressure and discomfort; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Oct2021 (Lot number: EW0196, Expiration Date: Dec2021) at the age of 26 years as dose 3 (booster dose), single for covid-19 immunisation. Relevant medical history included: "allergies" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Solution for injection, Anatomical Location: Left arm, Lot no: EL3247, Expiration: Unknown), administration date: 10Mar2021, when the patient was 26 years old, for COVID-19 Immunization; Bnt162b2 (Dose 2, Solution for injection, Anatomical Location: Left arm, Lot no: EL3247, Expiration: May2021), administration date: 31Mar2021, when the patient was 26 years old, for COVID-19 Immunization.  The following information was reported: SWELLING (non-serious) with onset 29Oct2021, outcome "recovering", described as "Swelling under his armpit"; DISCOMFORT (non-serious) with onset Oct2021, outcome "unknown", described as "He said that he feels a little pressure and discomfort".  Additional information: He received the booster shot from the Pfizer headquarters on 27Oct2021. Caller reported that he has some swelling under his armpit that he noticed this morning. Caller declined HCP information. He said that he felt a little pressure and discomfort, but would not say pain in any way. He thought it is going away anyways. Caller said that he felt discomfort when he raised his arm and he felt a little bump. Other Products was Yes. There was No Vaccine Administered at  Facility. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. AE(s) did not require a visit to Emergency Room and Physician Office. There were no Prior Vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine(s). There was no AE(s) following prior vaccinations. There was no Family Medical History Relevant to AE(s). There was no Relevant Tests.  No follow-up attempts are possible. No further information is expected.
Broken blood vessels in eye; Sinus infection type symptoms; Pigment color in eye different; Red streaks in eye; Blood shot and watery eyes; Didnt feel good; Body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EYE HAEMORRHAGE (Broken blood vessels in eye) and SINUSITIS (Sinus infection type symptoms) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cataract operation. Concurrent medical conditions included Glaucoma.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced EYE HAEMORRHAGE (Broken blood vessels in eye) (seriousness criterion medically significant), SINUSITIS (Sinus infection type symptoms) (seriousness criterion medically significant), EYE COLOUR CHANGE (Pigment color in eye different), OCULAR HYPERAEMIA (Red streaks in eye), LACRIMATION INCREASED (Blood shot and watery eyes), MYALGIA (Body aches) and MALAISE (Didnt feel good). At the time of the report, EYE HAEMORRHAGE (Broken blood vessels in eye), SINUSITIS (Sinus infection type symptoms), EYE COLOUR CHANGE (Pigment color in eye different), LACRIMATION INCREASED (Blood shot and watery eyes), MYALGIA (Body aches) and MALAISE (Didnt feel good) outcome was unknown and OCULAR HYPERAEMIA (Red streaks in eye) had not resolved.            Treatment included unknown steroid.; Sender's Comments: The event of sinus infection involves an infective origin, and hence assessed as unlikely related. Based on the information provided which includes a temporal association between the use of mRNA-1273 vaccine and onset of the other reported events, a causal relationship cannot be excluded. Myalgia is consistent with the product safety profile.
We recently vaccinated a few researchers Thursday 09/22 with the Jynneos vaccine intradermally. On Friday/Saturday 09/23 and 09/24 , she presented with fever (101F), pins and needles feeling in hands and feet, fatigue, chills, adjacent rash that was painful/itchy, and redness/pain/itching at injection site. The fever, fatigue, and chills, along with the pins and needles feeling resolved a day or so later along with the rash. The researcher also developed thrush along with their child that they breastfeed, who also developed a fever of 102F. The doctor said the child had a cold. They both were prescribed nystatin. On 09/30, there was only just a slightly pink, swollen, hard bump at the site of the injection. Of note, the researcher had a mild cold at time of vaccination.    (writer) has been in communication with agency.
Vaccine was given out of allowed time for vial puncture. vial was punctured 26 hours prior to use of vaccine. vaccine was stored in refridgerator the entire time.
A few days after, my scalp erupted again and I had lymph node enlargements behind my ear and at the base of hairline. I had terrible pain on left side where blisters swarmed again so I seen a healthcare provider and they couldn't figure out what was going on except that they asked me if I had a vaccine or booster recently and I hadn't given it much thought the first time it happened but now that it happened again I wonder if it was tired to my booster shot. She thought that the scalp eruption presented itself like a shingles reaction but I've had the shingles vaccine before and in the past so I know what they can be like. My lymph nodes are still swollen but Doctor said to give that more time and to follow up in a few weeks if it's still present.
I have alopecia arreata which had been in remission for 5 months or more. I had ahead full of healthy hair growing very well. After the first vaccine, in 7-10 days my hair sloughed.  It took only 2-3 days to completely fall out to a slick bald head. After the second dose EP6955 Pfizer, in the days and weeks to follow, I noticed hair loss of eyebrows, eyelashes, nasal hair,  and all body hair.  Also, profound itching and tingling of skin on my abdomen, chest, arms and legs.My diagnosis has been updated to alopecia universalis.   1st vaccine 2/26/2021   2nd vaccine 3/19/2021  reaction start date 3/6/2021
Patients father states "child had one bumplike area on mid right cheek on the evening of 6/19/07 did not complain about anything, woke up this morning with several red itchy bumplike areas on forehead and cheeks, only on face nowhere else." Patient and her father came to clinic on 6/20/07 to be seen. Dr. examined patient and determined that patient had mild case of chicken pox, and talked with patient and her father medication was ordered for the patient.
tested + for covid  2-13-22  ;  deceased 3-6-22;  I have no other information Had two covid vaccines 1-11-21 and 2-1-21   both pfizer
Vaccinated with Varivax on 2/28/02. Reported dx of chickenpox on 5/12/03.
Presented as a head cold, several days into the Covid had difficulty breathing, hence the reason for the admission to the hospital.
At around 1700, 10 minutes after getting covid vaccine, patient told mom that he was feeling very tired. Laid down on table and mom noticed she could really see the pulse in his neck. Blood pressure, pulse and O2 was taken.
CERTIFICATE SHOWS THAT PATIENT RECEIVED TRUMENBA AT 11 YEARS OF AGE. PATIENT'S ARE NOT SUPPOSE TO RECEIVE THIS VACCINE UNTIL AGE 16. THIS MAY HAVE BEEN ENTER IN ERROR AND MAY NEED PROOF.
Patient began developing rash and reddness on left hand approximately 15-10 minutes after receiving vaccine. Vitals were taken with BP of 120/61 and pr of 85. Patient currently being monitored for 30 minutes. Patient was instructed to follow up with PCM regarding incident. Pt does not have any other symptoms. Pt states having rash from previous influenza shot, however this incident being less severe than the last.
pt exp swelling, heat, redness @ site of inj;48hrs later pt exp projectile vomiting & hot & cold flashes;pt applied ice to site & rested @ home
Patient states she developed shingles secondary to her shingles shot. There is a large rash on her right arm, but today (3/14/23) is 2 weeks post-vaccine, not typical of shingles presentation, and the location is on forearm below elbow (not in right deltoid)
Information has been received from a pharmacist and refers to a patient of unknown age and gender. There was no information about patient's concurrent conditions, medical history or concomitant medications. On unspecified dates, the patient was vaccinated with a dose of improperly stored ZOSTAVAX lot # N016185 and expiration date of 31-JUL-2018, (route of administration and anatomical location were not reported) for prophylaxis, which were stored in the range of 15 Fahrenheit degrees to 46 Fahrenheit degrees for 23 hours. Vaccine was reconstituted with properly stored  sterile diluent (MERCK STERILE DILUENT). No previous temperature excursion was reported.  No adverse effects were reported. Digital data logger was involved. This is one of several reports from the same source.; Sender's Comments: US-009507513-1712USA013912: US-009507513-1712USA001694:
right eye was swollen with some discoloration on the eye lid and outer skin surrounding the eye/feeling pressure related to the swelling; right eye was swollen with some discoloration on the eye lid and outer skin surrounding the eye; this patient received the Jansen COVID-19 vaccine as her primary COVID-19 vaccination.; this patient received the Jansen COVID-19 vaccine as her primary COVID-19 vaccination.; This is a spontaneous report from a contactable pharmacist via medical information team.  A 54-year-old female patient received bnt162b2 (COMIRNATY, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration, on 30Oct2021 (Saturday) (age at vaccination: 54 years), as a dose 2 (booster), single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient historical vaccine includes JANSSEN COVID-19 VACCINE started on an unspecified date for primary COVID-19 vaccination. On 31Oct2021 (Sunday), the patient started having a strange reaction.The reporter stated that the patient woke up Sunday and noticed that her right eye was swollen with some discoloration on the eye lid and outer skin surrounding the eye.The patient reported no changes in vision and no pain associated with the swelling but did endorse feeling pressure related to the swelling. The reporter also stated that there was no drainage from the eye. The reporter told the patient to take a Benadryl in the event that this may be a delayed allergic reaction.The reporter spoke with the patient this morning and her symptoms were still the same with no improvement.The caller advised the patient to see her medical doctor for evaluation.The caller would like to know if swelling of the eye one day post vaccination was a side effect that had been reported with the Pfizer COVID-19 vaccine.The reporter declined warm transfer at this time due to being at work with patients waiting on her at the pharmacy. The caller did ask for the website for online reporting. Provided caller with withheld, however, she had not reported online at this time yet. She states that she was currently reporting online to VAERS at the time of this call. Reportedly the response provided regarding delayed non-severe allergic reactions including swelling of the face. The outcome was not recovered for the event right eye was swollen with some discoloration on the eye lid and outer skin surrounding the eye.  The lot number for the vaccine [BNT162B2] was not provided and will be requested during follow up.
5/7/21 about 9pm my neck got sore. Went to bed. I was very very tired and achy the next morning and went to work an hour late, stayed at work about an hour, went home and slept the entire day and most of the night and the same the next day. Very sleepy and achy. A little nauseous both fats but no vomiting. I did use my sumutriptan injection for 3 days in a row beginning the day after the shot for migraine but not truly a headache. I attribute the migraine to hormones. (I track my migraines and get them nearly to the day monthly).  About 4 days after getting the shot I had a red, itchy area about 6 inches long and 3 inches wide surrounding the injection site. It lasted 4 days and faded.
Men B given instead of Men Conjugate , Nurse to verify MCIR prior to giving any further immunizations.
Auditory, visual, and olfactory, hallucinations began about 6 hours after vaccination and continued for roughly 15 hours.  other side effects included those commonly listed, headache, nausea, fever, chills.
PATIENT STATES FEELS FLUSH AND DIZZY. VITAL SIGNS STABLE 130/90 BP, 85 HR, 99% O2. PATIENT OBSERVED ADDITIONAL 15 MINS. PATIENT STATES SHE FEELS BETTER AND IS RELEASED.